Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-008277
Filing Date
2022-02-09
Accepted
2022-02-09 21:31:31
Documents
2
Period of Report
2022-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1603
2 EX-24 DOCUMENT attachment1.htm EX-24 2616
  Complete submission text file 0001209191-22-008277.txt   5683
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O KURA ONCOLOGY, INC. 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address
GRASSO MARC (Reporting) CIK: 0001748894 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38792 | Film No.: 22609315